Recruiting NCT07488377
Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Cognitive Self-Efficacy Questionnaire (Turkish Version).
- Who it may be relevant to
- Registry conditions: Parkinson Disease. Basic parameters: 40 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Validity and Reliability of the Turkish Version of the Cognitive Self-Efficacy Questionnaire in Individuals With Parkinson's Disease
Overview
This study aims to evaluate the validity and reliability of the Turkish version of the Cognitive Self-Efficacy Questionnaire in individuals with Parkinson's disease.
Interventions
- Other Cognitive Self-Efficacy Questionnaire (Turkish Version)
Participants will complete the Turkish version of the Cognitive Self-Efficacy Questionnaire to assess cognitive self-efficacy. The questionnaire will be administered for the evaluation of its validity and reliability in individuals with Parkinson's disease.
Primary outcome measures
- Validity and Reliability of the Turkish Version of the Cognitive Self-Efficacy Questionnaire (CSEQ) [Time frame: Baseline and 14-21 days for test-retest assessment]
Secondary outcome measures (2)
- Self-Efficacy for Managing Chronic Disease (6-Item Scale) [Time frame: Baseline]
- Montreal Cognitive Assessment (MoCA-TR) [Time frame: Baseline]
Eligibility criteria
Inclusion criteria
- Clinical diagnosis of Parkinson's disease
- Hoehn and Yahr stage 1-3
- Age 40 to 85 years
- Mini-Mental State Examination (MMSE) score ≥24
- Able to communicate and complete study assessments
- Attending the Movement Disorders Outpatient Clinic, Department of Neurology, Istanbul Cerrahpaşa Faculty of Medicine Hospital
- Able and willing to provide written informed consent
Exclusion criteria
- Major depressive disorder or psychotic disorder
- Advanced dementia
- Severe visual impairment that may interfere with study assessments
- Severe hearing impairment that may interfere with study assessments
- Inability to cooperate with the physiotherapist
- Inability to complete the study assessments
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Turkey (Türkiye) · 1 center
- Acibadem University — Istanbul
Identifiers
NCT: NCT07488377 · 2026-05-223